Clinical Trial Update: Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing transcatheter arterial chemoembolization (TACE) with arsenic trioxide versus TACE alone for primary hepatocellular carcinoma; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Hunan Provincial People's Hospital | Conditions: Primary Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN